Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services is an integrated contract development and manufacturing company that provides comprehensive development, CGMP manufacturing, and sterile filling finishing services for small-molecule and large-molecule APIs and intermediates. The company offers a wide range of innovative platforms and capabilities for commercial-scale preclinical and pilot programs, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody-drug conjugates (ADC), high-potency APIs (HPAPI), biocatalysis, continuous flow manufacturing, and more. The company is committed to delivering high-quality services to meet customer needs, with the mission of helping to improve human health. Its ultimate goal is to provide adaptive solutions, rapid-response services, trustworthy partnerships, and a reassuring environment for its clients through innovation, accountability, compliance, communication, and teamwork.